For additional Important Safety Information, please see the Rituxan full Prescribing Information, including BOXED WARNINGS. *Ritux 3 regimen = Roche-manufactured, EU-approved rituximab product EU=European Union Attention Healthcare Provider: Provide Medication Guide to patient prior to Rituxan infusion. ...
For additional Important Safety Information, please see the Rituxan full Prescribing Information, including BOXED WARNINGS. *Ritux 3 regimen = Roche-manufactured, EU-approved rituximab product EU=European Union Attention Healthcare Provider: Provide Medication Guide to patient prior to Rituxan infusion. ...
Concise Info
Get answers to common questions people have about treatment with Rituxan. You'll find tips for knowing when it might be time for another approach to your RA treatment. Please keep in mind that the information provided here should not replace a conversation with your doctor.Get...
For additional Important Safety Information, please see the Rituxan full Prescribing Information, including BOXED WARNINGS. *Ritux 3 regimen = Roche-manufactured, EU-approved rituximab product EU=European Union Attention Healthcare Provider: Provide Medication Guide to patient prior to Rituxan infusion. ...
TRUXIMA is not indicated for treatment of children. IMPORTANT SAFETY INFORMATION TRUXIMA can cause serious side effects that can lead to death, including: Infusion-related reactions.Infusion-related reactions are very common side effects of TRUXIMA treatment. Serious infusion-related reactions can happe...
You may also report side effects to Genentech at (888) 835-2555. For additional safety information, please see the full Prescribing Information, including BOXED WARNINGS and Medication Guide. Attention Healthcare Provider: Provide Medication Guide to patient prior to Rituxan infusion....
For additional safety information, please see the full Prescribing Information including BOXED WARNINGS and Medication Guide. Attention Healthcare Provider: Provide Medication Guide to patient prior to RITUXAN infusion. You may report side effects to the FDA at 800-FDA-1088 or www.fda.gov/medwatch...
In combination with glucocorticoids, for the treatment of adult patients with GPA and MPA IMPORTANT SAFETY INFORMATION WARNING: FATAL INFUSION-RELATED REACTIONS, SEVERE MUCOCUTANEOUS REACTIONS, HEPATITIS B VIRUS REACTIVATION and PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY Infusion-Related Reactions: Administration...
RIABNI™ (rituximab-arrx) is indicated for the treatment of adult patients with: Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent...Read more Indications Prescribing Information Medication Guide Visit AmgenBiosimilars.com New...